Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia
- PMID: 2703526
- PMCID: PMC303797
- DOI: 10.1172/JCI113991
Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia
Abstract
Tumor necrosis factor (TNF) administration produces an increase in plasma triglycerides that may be due to inhibition of adipose lipoprotein lipase activity and/or a stimulation of hepatic lipogenesis. We now report that TNF administration to insulinopenic diabetic rats increases serum triglycerides (2 h, 2.4-fold; 17 h, 4.3-fold). Adipose tissue lipoprotein lipase activity was markedly decreased in diabetic animals compared with controls and was not further inhibited by TNF. Incorporation of tritiated water into fatty acids in the liver was increased 45% 1-2 h after TNF and 87% at 16-17 h. These results indicate that the TNF-induced increase in circulating lipid levels can occur in the absence of a TNF-induced inhibition of adipose tissue lipoprotein lipase activity. Moreover, the clearance from the circulation of triglycerides in chylomicrons was similar in control and TNF-treated animals; these results provide further evidence that the removal of triglyceride-rich lipoproteins is not altered in the TNF-treated animals. Our data suggest that the TNF-induced stimulation of hepatic lipid synthesis may play an important role in the increase in serum triglycerides. In addition, TNF administration to diabetic animals leads to an elevation in serum glucose levels (73% at 17 h) without a change in serum insulin levels. Thus, TNF stimulation of hepatic lipogenesis is independent of changes in insulin.
Similar articles
-
Tumor necrosis factor-increased hepatic very-low-density lipoprotein production and increased serum triglyceride levels in diabetic rats.Diabetes. 1990 Dec;39(12):1569-74. doi: 10.2337/diab.39.12.1569. Diabetes. 1990. PMID: 1978829
-
Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1106-16. doi: 10.1152/ajpendo.90260.2008. Epub 2008 Sep 9. Am J Physiol Endocrinol Metab. 2008. PMID: 18780778
-
Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo.J Clin Invest. 1987 Jul;80(1):184-90. doi: 10.1172/JCI113046. J Clin Invest. 1987. PMID: 3597772 Free PMC article.
-
Role of cytokines in inducing hyperlipidemia.Diabetes. 1992 Oct;41 Suppl 2:97-101. doi: 10.2337/diab.41.2.s97. Diabetes. 1992. PMID: 1526345 Review.
-
[Insulin sensitiviy and lipids].Diabetes Metab. 2001 Apr;27(2 Pt 2):223-7. Diabetes Metab. 2001. PMID: 11452214 Review. French.
Cited by
-
Metabolic Messengers: tumour necrosis factor.Nat Metab. 2021 Oct;3(10):1302-1312. doi: 10.1038/s42255-021-00470-z. Epub 2021 Oct 14. Nat Metab. 2021. PMID: 34650277 Review.
-
The impact of metabolic disorders on management of periodontal health in children.Pediatr Discov. 2024 Mar;2(1):e38. doi: 10.1002/pdi3.38. Epub 2023 Nov 3. Pediatr Discov. 2024. PMID: 38784180 Free PMC article.
-
Inflammation in obesity, diabetes, and related disorders.Immunity. 2022 Jan 11;55(1):31-55. doi: 10.1016/j.immuni.2021.12.013. Immunity. 2022. PMID: 35021057 Free PMC article. Review.
-
Foundations of Immunometabolism and Implications for Metabolic Health and Disease.Immunity. 2017 Sep 19;47(3):406-420. doi: 10.1016/j.immuni.2017.08.009. Immunity. 2017. PMID: 28930657 Free PMC article. Review.
-
Effects of platelet-activating factor on lipid metabolism in rats in vivo. Origin of the hypertriglyceridaemia.Biochem J. 1991 Dec 1;280 ( Pt 2)(Pt 2):541-3. doi: 10.1042/bj2800541. Biochem J. 1991. PMID: 1747129 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources